Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases.
Business Model:
Revenue: $18M
Employees: 51-200
Crescendo Bioscience was acquired by
Myriad Genetics.
The acquisition happend on 2014-02-04.
Details of the transaction were not public
Address: 341 Oyster Point Blvd.
City: South San Francisco
State: CA
Zip: 94080
Country: US
Crescendo Bioscience develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases.
Contact Phone:
+16503511354
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2011 | Series C | $31M | 12/2012 | Series D | $28.5M | 9/2011 | Debt Financing | $25M | 3/2007 | Series A | 1 | $5.1M |
Mohr Davidow Ventures Mohr Davidow Ventures |
1/2013 | Series D | 5 | $28M |
Mohr Davidow Ventures Skyline Ventures Safeguard Scientifics Kleiner Perkins Aeris Capital Safeguard Scientifics Skyline Ventures Mohr Davidow Ventures Skyline Ventures Safeguard Scientifics Kleiner Perkins Aeris Capital Safeguard Scientifics Skyline Ventures |
9/2011 | Series C | 3 | $56M |
Kleiner Perkins Mohr Davidow Ventures Aeris Capital Aeris Capital Kleiner Perkins Mohr Davidow Ventures Aeris Capital Aeris Capital |
6/2008 | Series B | 2 | $15M |
Kleiner Perkins Mohr Davidow Ventures Kleiner Perkins Mohr Davidow Ventures |
7/2010 | Series B | 2 | $37.6M |
Kleiner Perkins Mohr Davidow Ventures Kleiner Perkins Mohr Davidow Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|